TWST

Conviction 95HealthcareScan · Mon, Aug 10, 2026

TWST$124.75+7.85%

ResistanceSupportVol 14Insider sell

Vol MA14 1.73M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Twist Bioscience CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.twistbioscience.com ↗

Price124.75

Change+7.85%

Gap-0.62%

Rel volume1.77×

Avg volume1.57M

Avg $ vol156.91M

SMA 2096.95

SMA 5089.39

SMA 20054.97

Price vs 50+39.56%

Price vs 200+126.94%

MA stackbullish

50/200 cross—

Supertrendup · 93.10

RSI (14)72

MACD hist2.89

MACD crossbull · 4d

Stoch %K / %D98 / 91

ADX (14)30

+DI / −DI33 / 9

RSI divergence—

MACD divergenceBullish

ATR %+6.70%

ADR %7.94%

52w high124.75

52w low24.16

From 52w high+0.00%

Above 52w low+416.33%

New 52w highYes

SqueezeOff

Bollinger width43.62%

%B1.16

Donchian pos98.04%

Donchian high125.63

Donchian low80.59

AVWAP (52w high)121.49

vs AVWAP high+2.68%

AVWAP (52w low)59.60

vs AVWAP low+109.32%

OBV trendUp

Chaikin MF (20)0.22

Today vs 20d1.77×

Avg vol (14d)1.73M

Avg vol (20d)1.57M

Avg $ vol (20d)156.91M

Market cap7.82B

RS 3m (vs SPY)+91.89%

RS 6m (vs SPY)+131.47%

RS line new highYes

Trend template8/8

Technical rank97.0

1 week+23.44%

1 month+37.63%

3 months+119.43%

6 months+153.34%

1 year+398.98%

YTD+285.13%

P/E-100.71

P/B17.55

P/S20.77

P/FCF-103.43

EPS-1.30

Div yield—

ROE-17.42%

ROA-11.55%

Debt/Eq0.00

Current2.67

EV/EBITDA-69.17

Gross margin—

Net margin-20.63%

Rev growth20.32%

EPS growth62.79%

Price target109.88

Target upside-11.92%

Analyst ratingBuy

Institutional131.32%

Ent. value7.71B

Revenue118.38M

Net income-35.05M

Gross profit—

Free cash flow-75.63M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out62.27M

Employees979

ListedWed, Oct 31, 2018

Free float52.76M

Float %86.1%

Short interest14.12M

Days to cover9.7d

Short volume53.5%

Squeeze score86 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.56 vs −$0.50

Last surprise-12.0% miss

Setup gradeA+

Conviction95 / 100

Pattern quality—

Tech rank97.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance104.85

Support81.07

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TWST

All disclosures →

No recent disclosed trades by Congress in TWST. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TWST · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Cho Dennis See Remarks · Common Stock · 2026-08-05	Sell	14.21K	$1.6M	2026-08-05	2026-08-07
Cho Dennis See Remarks · Common Stock · 2026-08-03	Sell	1.07K	$91K	2026-08-03	2026-08-05
Finn Patrick John President and COO · Common Stock · 2026-08-03	Sell	2.89K	$246K	2026-08-03	2026-08-05
Green Paula SVP of Human Resources · Common Stock · 2026-08-03	Sell	1.13K	$97K	2026-08-03	2026-08-05
Leproust Emily M. Chief Executive Officer · Common Stock · 2026-08-03	Sell	5.1K	$435K	2026-08-03	2026-08-05
Finn Patrick John President and COO · Common Stock · 2026-07-23	Sell	2.24K	$210K	2026-07-23	2026-07-27
Laponis Adam Chief Financial Officer · Common Stock · 2026-07-09	Sell	2.4K	$226K	2026-07-09	2026-07-13
Cho Dennis See Remarks · Common Stock · 2026-06-24	Sell	14.21K	$1.3M	2026-06-24	2026-06-26
Cho Dennis See Remarks · Common Stock · 2026-06-22	Sell	346	$30K	2026-06-22	2026-06-24
WERNER ROBERT F. Chief Accounting Officer · Common Stock · 2026-06-08	Sell	232	$16K	2026-06-08	2026-06-10

SEC filings

EDGAR filings in TWST · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.